vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and CARTERS INC (CRI). Click either name above to swap in a different company.
CARTERS INC is the larger business by last-quarter revenue ($757.8M vs $487.7M, roughly 1.6× CLOVER HEALTH INVESTMENTS, CORP.). CARTERS INC runs the higher net margin — 1.5% vs -10.1%, a 11.6% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs -0.1%). CLOVER HEALTH INVESTMENTS, CORP. produced more free cash flow last quarter ($-69.0M vs $-144.1M).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Carter's, Inc. is a major American designer and marketer of children's apparel. It was founded in 1865 by William Carter.
CLOV vs CRI — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $757.8M |
| Net Profit | $-49.3M | $11.6M |
| Gross Margin | — | 45.1% |
| Operating Margin | -10.1% | 3.8% |
| Net Margin | -10.1% | 1.5% |
| Revenue YoY | 44.7% | -0.1% |
| Net Profit YoY | -123.2% | -80.1% |
| EPS (diluted) | — | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | — | ||
| Q3 25 | $496.6M | $757.8M | ||
| Q2 25 | $477.6M | $585.3M | ||
| Q1 25 | $462.3M | $629.8M | ||
| Q4 24 | $337.0M | — | ||
| Q3 24 | $331.0M | — | ||
| Q2 24 | $356.3M | — | ||
| Q1 24 | $346.9M | — |
| Q4 25 | $-49.3M | — | ||
| Q3 25 | $-24.4M | $11.6M | ||
| Q2 25 | $-10.6M | $446.0K | ||
| Q1 25 | $-1.3M | $15.5M | ||
| Q4 24 | $-22.1M | — | ||
| Q3 24 | $-9.2M | — | ||
| Q2 24 | $7.4M | — | ||
| Q1 24 | $-19.2M | — |
| Q4 25 | — | — | ||
| Q3 25 | — | 45.1% | ||
| Q2 25 | — | 48.1% | ||
| Q1 25 | — | 46.2% | ||
| Q4 24 | — | — | ||
| Q3 24 | 24.5% | — | ||
| Q2 24 | 30.3% | — | ||
| Q1 24 | 23.6% | — |
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 3.8% | ||
| Q2 25 | -2.2% | 0.7% | ||
| Q1 25 | -0.3% | 4.1% | ||
| Q4 24 | -6.4% | — | ||
| Q3 24 | -2.7% | — | ||
| Q2 24 | 2.0% | — | ||
| Q1 24 | -6.5% | — |
| Q4 25 | -10.1% | — | ||
| Q3 25 | -4.9% | 1.5% | ||
| Q2 25 | -2.2% | 0.1% | ||
| Q1 25 | -0.3% | 2.5% | ||
| Q4 24 | -6.6% | — | ||
| Q3 24 | -2.8% | — | ||
| Q2 24 | 2.1% | — | ||
| Q1 24 | -5.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | $0.32 | ||
| Q2 25 | — | $0.01 | ||
| Q1 25 | — | $0.43 | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $184.2M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $308.7M | $864.6M |
| Total Assets | $541.0M | $2.5B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | — | ||
| Q3 25 | — | $184.2M | ||
| Q2 25 | — | $338.2M | ||
| Q1 25 | — | $320.8M | ||
| Q4 24 | $194.5M | — | ||
| Q3 24 | $288.0M | — | ||
| Q2 24 | $254.8M | — | ||
| Q1 24 | $208.3M | — |
| Q4 25 | $308.7M | — | ||
| Q3 25 | $340.9M | $864.6M | ||
| Q2 25 | $344.2M | $853.9M | ||
| Q1 25 | $336.1M | $847.2M | ||
| Q4 24 | $341.1M | — | ||
| Q3 24 | $342.2M | — | ||
| Q2 24 | $324.9M | — | ||
| Q1 24 | $292.5M | — |
| Q4 25 | $541.0M | — | ||
| Q3 25 | $559.7M | $2.5B | ||
| Q2 25 | $575.0M | $2.5B | ||
| Q1 25 | $583.7M | $2.3B | ||
| Q4 24 | $580.7M | — | ||
| Q3 24 | $653.0M | — | ||
| Q2 24 | $674.2M | — | ||
| Q1 24 | $671.8M | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | $-128.0M |
| Free Cash FlowOCF − Capex | $-69.0M | $-144.1M |
| FCF MarginFCF / Revenue | -14.1% | -19.0% |
| Capex IntensityCapex / Revenue | 0.4% | 2.1% |
| Cash ConversionOCF / Net Profit | — | -11.04× |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | — | ||
| Q3 25 | $12.1M | $-128.0M | ||
| Q2 25 | $5.4M | $40.3M | ||
| Q1 25 | $-16.3M | $-48.6M | ||
| Q4 24 | $34.8M | — | ||
| Q3 24 | $50.0M | — | ||
| Q2 24 | $44.8M | — | ||
| Q1 24 | $25.9M | — |
| Q4 25 | $-69.0M | — | ||
| Q3 25 | $11.4M | $-144.1M | ||
| Q2 25 | $4.8M | $24.1M | ||
| Q1 25 | $-16.5M | $-59.0M | ||
| Q4 24 | $33.3M | — | ||
| Q3 24 | $49.6M | — | ||
| Q2 24 | $44.4M | — | ||
| Q1 24 | $25.5M | — |
| Q4 25 | -14.1% | — | ||
| Q3 25 | 2.3% | -19.0% | ||
| Q2 25 | 1.0% | 4.1% | ||
| Q1 25 | -3.6% | -9.4% | ||
| Q4 24 | 9.9% | — | ||
| Q3 24 | 15.0% | — | ||
| Q2 24 | 12.5% | — | ||
| Q1 24 | 7.3% | — |
| Q4 25 | 0.4% | — | ||
| Q3 25 | 0.1% | 2.1% | ||
| Q2 25 | 0.1% | 2.8% | ||
| Q1 25 | 0.0% | 1.6% | ||
| Q4 24 | 0.5% | — | ||
| Q3 24 | 0.1% | — | ||
| Q2 24 | 0.1% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | -11.04× | ||
| Q2 25 | — | 90.37× | ||
| Q1 25 | — | -3.13× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 6.04× | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
CRI
| Sales Channel Directly To Consumer | $362.3M | 48% |
| Sales Channel Through Intermediary | $283.8M | 37% |
| Other | $110.4M | 15% |
| Gift Cards | $1.3M | 0% |
